9/22/2020China Increases Prices of Key Drug Ingredients by Up To 20%, Pressurin...

8/6/2020U.S. Introduces A 'Buy American First' Pharma Executive Order

6/30/2020Fitch: No Near-Term Impact on Chinese API Makers as Pharma Supply-Chai...

6/16/2020Indian Firms Challenged by API Price Hikes by Chinese Suppliers

4/27/2020Snapshot of the Chinese API Sector

4/13/2020India to Boost API Output as Alternative Source to China

4/7/2020India Lifts Export Restrictions on 24 APIs

4/1/2020China Claims Resumption of API Manufacture as Freight and India Bottle...

3/31/2020China Vows to Further Stabilize Production, Supply of Active Pharmaceu... (Free)

3/25/2020China Begins Export of Many Pharma Ingredients to India

3/16/2020U.S. Eyes Puerto Rico As Alternative to Chinese APIs

3/11/2020China-controlled Penicillin G API Sees over 50% Price Hike

3/11/2020EMA to Consider Coronavirus' Impact on EU Medicines Supply

3/11/2020Trump to Issue Executive Order Aimed At Ending Medical and API Relianc...

3/4/2020India Bans Export of 26 Key Active Pharma Ingredients

2/27/2020Indian Govt to Fly Raw Materials from Coronavirus-hit China for Cipla

2/26/2020FDA Catches Lies and Violations of Chinese Heparin Producer Yibin Liha...

2/24/2020Sanofi to Compete in API Sector against China and India with New Compa...

2/17/2020India May Soon Impose Temporary Export Ban on Numerous Essential Medic...

2/12/2020U.S. Senior Official Urges to Reduce Dependence on Chinese Drug Suppli...

2/2/2020Coronavirus Outbreak to Disrupt Supplies of Drug Ingredients to Indian...

2/2/2020Coronavirus Threatens Global API Sourcing from China

2/2/2020Coronavirus A Growing Threat To Global Supply Chains - Pharma Being Hi...

11/5/2019Nikkei: Japan's Generic Drugmakers Have A China Dependency Problem

10/28/2019Korea's Growing Reliance on China for API Supply Flagged

10/28/2019WuXi STA's Jinshan Facility Passes EMA Inspection

Page:1/1 Total number of articles:26: [First][<<] [1] [>>] [End]